74 related articles for article (PubMed ID: 29305565)
1. GSTP1 methylation in cancer: a liquid biopsy biomarker?
Gurioli G; Martignano F; Salvi S; Costantini M; Gunelli R; Casadio V
Clin Chem Lab Med; 2018 Apr; 56(5):702-717. PubMed ID: 29305565
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients.
Aykanli E; Arisan S; Arisan ED; Yavuzsan AH
Urol J; 2024 May; 21(3):182-188. PubMed ID: 38493315
[TBL] [Abstract][Full Text] [Related]
3. Promoter hypermethylation of RARB and GSTP1 genes in plasma cell-free DNA as breast cancer biomarkers in Peruvian women.
Danos P; Giannoni-Luza S; Murillo Carrasco AG; Acosta O; Guevara-Fujita ML; Cotrina Concha JM; Guerra Miller H; Pinto Oblitas J; Aguilar Cartagena A; Araujo JM; Fujita R; Buleje Sono JL
Mol Genet Genomic Med; 2023 Dec; 11(12):e2260. PubMed ID: 37548362
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers in prostate cancer epidemiology.
Verma M; Patel P; Verma M
Cancers (Basel); 2011 Sep; 3(4):3773-98. PubMed ID: 24213111
[TBL] [Abstract][Full Text] [Related]
5. [Ⅱ. Current Status of Liquid Biopsy in Prostate Cancer].
Hashimoto K; Masumori N
Gan To Kagaku Ryoho; 2024 Jan; 51(1):31-35. PubMed ID: 38247088
[No Abstract] [Full Text] [Related]
6. Electrochemical Assay of GSTP1-related DNA Sequence for Prostrate Cancer Screening.
Saheb AH; Leon M; Josowicz M
Electrochem Soc Interface; 2012; 21(3-4):71-75. PubMed ID: 25284970
[No Abstract] [Full Text] [Related]
7. Blood Collection and Cell-Free DNA Isolation Methods Influence the Sensitivity of Liquid Biopsy Analysis for Colorectal Cancer Detection.
Barták BK; Kalmár A; Galamb O; Wichmann B; Nagy ZB; Tulassay Z; Dank M; Igaz P; Molnár B
Pathol Oncol Res; 2019 Jul; 25(3):915-923. PubMed ID: 29374860
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic markers in circulating cell-free DNA as prognostic markers for survival of castration-resistant prostate cancer patients.
Hendriks RJ; Dijkstra S; Smit FP; Vandersmissen J; Van de Voorde H; Mulders PFA; van Oort IM; Van Criekinge W; Schalken JA
Prostate; 2018 Apr; 78(5):336-342. PubMed ID: 29330943
[TBL] [Abstract][Full Text] [Related]
9. Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer.
Pugongchai A; Bychkov A; Sampatanukul P
Int J Exp Pathol; 2017 Dec; 98(6):341-346. PubMed ID: 29315911
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance and association of GSTP1 hypermethylation with hepatocellular carcinoma: A meta-analysis.
Li Y; Cai Y; Chen H; Mao L
J Cancer Res Ther; 2018 Jun; 14(Supplement):S486-S489. PubMed ID: 29970711
[TBL] [Abstract][Full Text] [Related]
11. GSTP1 and cancer: Expression, methylation, polymorphisms and signaling (Review).
Cui J; Li G; Yin J; Li L; Tan Y; Wei H; Liu B; Deng L; Tang J; Chen Y; Yi L
Int J Oncol; 2020 Apr; 56(4):867-878. PubMed ID: 32319549
[TBL] [Abstract][Full Text] [Related]
12. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Biomarkers in Cell-Free DNA and Applications in Liquid Biopsy.
Gai W; Sun K
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30634483
[TBL] [Abstract][Full Text] [Related]
14. Impact of SNP-SNP interactions of DNA repair gene
Sang L; Lv Z; Sun LP; Xu Q; Yuan Y
World J Gastroenterol; 2018 Feb; 24(5):602-612. PubMed ID: 29434449
[TBL] [Abstract][Full Text] [Related]
15. Urinary DNA methylation biomarkers for prediction of prostate cancer upgrading and upstaging.
Bakavicius A; Daniunaite K; Zukauskaite K; Barisiene M; Jarmalaite S; Jankevicius F
Clin Epigenetics; 2019 Aug; 11(1):115. PubMed ID: 31383039
[TBL] [Abstract][Full Text] [Related]
16. A Covalent Inhibitor for Glutathione S-Transferase Pi (GSTP
Shishido Y; Tomoike F; Kuwata K; Fujikawa H; Sekido Y; Murakami-Tonami Y; Kameda T; Abe N; Kimura Y; Shuto S; Abe H
Chembiochem; 2019 Apr; 20(7):900-905. PubMed ID: 30548113
[TBL] [Abstract][Full Text] [Related]
17. A urine-based DNA methylation assay, ProCUrE, to identify clinically significant prostate cancer.
Zhao F; Olkhov-Mitsel E; Kamdar S; Jeyapala R; Garcia J; Hurst R; Hanna MY; Mills R; Tuzova AV; O'Reilly E; Kelly S; Cooper C; ; Brewer D; Perry AS; Clark J; Fleshner N; Bapat B
Clin Epigenetics; 2018 Nov; 10(1):147. PubMed ID: 30470249
[TBL] [Abstract][Full Text] [Related]
18. DNA Methylation-Based Testing in Liquid Biopsies as Detection and Prognostic Biomarkers for the Four Major Cancer Types.
Constâncio V; Nunes SP; Henrique R; Jerónimo C
Cells; 2020 Mar; 9(3):. PubMed ID: 32150897
[TBL] [Abstract][Full Text] [Related]
19. GSTP1 as a Potential Marker of Early Chemotherapy Response for Noninvasive Detection.
Izumchenko E; Shavit Grievink L; Rosenbaum E; Hoque MO
Eur Urol; 2019 Sep; 76(3):313-314. PubMed ID: 30642610
[No Abstract] [Full Text] [Related]
20. Molecular Insights into the Breast and Prostate Cancer Cells in Response to the Change of Extracellular Zinc.
Barman SK; Sen MK; Mahns DA; Wu MJ; Malladi CS
J Oncol; 2024; 2024():9925970. PubMed ID: 38249992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
